| NCT06148090
| Screening for Adrenal Insufficiency During Dermocorticoid Reduction in Bullous Pemphigoid (BP) | No drug interventions | prevention | Not Available | recruiting |
| NCT04499235
| A Study to Assess the Therapeutic Effect and Safety of Adjunctive AKST4290 in Subjects With Bullous Pemphigoid | | treatment | 2 | terminated |
| NCT04465292
| The Effects of Tildrakizumab in Treatment of Bullous Pemphigoid | | treatment | 0 | unknown_status |
| NCT03856840
| Cytokines in Blister Fluids of Bullous Pemphigoid (BP) | No drug interventions | Not Available | Not Available | completed |
| NCT01705795
| Anti-IL-5 Therapy in Bullous Pemphigoid (BP) | | treatment | 2 | completed |
| NCT01559155
| Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid | No drug interventions | Not Available | Not Available | terminated |
| NCT02226146
| Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid | | treatment | 2 | completed |
| NCT05681481
| A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants with Bullous Pemphigoid | | treatment | 3 | active_not_recruiting |
| NCT00802243
| Leflunomide Associated With Topical Corticosteroids for Bullous Pemphigoid | | treatment | 2 | unknown_status |
| NCT00213421
| Comparison of Two Therapeutic Strategies of Dermoval in Treatment of Bullous Pemphigus | No drug interventions | Not Available | Not Available | completed |
| NCT04641884
| Bullous Pemphigoid Induced by antiPD-1/PDL-1 Therapy | No drug interventions | Not Available | Not Available | unknown_status |
| NCT05649579
| Efficacy and Safety of Dupilumab in Patients With Bullous Pemphigoid | | Not Available | Not Available | completed |
| NCT04728854
| Telederm and Bullous Pemphigoid | No drug interventions | Not Available | Not Available | completed |
| NCT02753777
| Autoimmune Blistering Diseases Study | No drug interventions | Not Available | Not Available | recruiting |
| NCT03320798
| Impact of Neurological Diseases on the Prognosis of Bullous Pemphigoid: A Retrospective Study of 178 Patients | No drug interventions | Not Available | Not Available | completed |
| NCT06561256
| JAK Inhibitors' Efficacy in Bullous Pemphigoid | No drug interventions | Not Available | Not Available | completed |
| NCT04117932
| Efficacy and Safety of Ustekinumab in Bullous Pemphigoid | | treatment | 2 | completed |
| NCT02313870
| Topical Steroids Alone or Associated With Methotrexate in Bullous Pemphigoid | | treatment | 3 | completed |
| NCT00431119
| Azathioprine or Mycophenolate Mofetil for Bullous Pemphigoid | | treatment | 2 | completed |
| NCT00525616
| Efficiency and Tolerance of Rituximab (mabthéra) in Bullous Pemphigoid | | treatment | 3 | completed |
| NCT03272958
| Clinical Characteristics of Pruritus and Evaluation of Quality of Life in Patients With Bullous Pemphigoid | No drug interventions | Not Available | Not Available | completed |
| NCT00286325
| Rituximab in the Treatment of Patients With Bullous Pemphigoid | | treatment | 1 / 2 | completed |
| NCT03286582
| A Proof-of-Concept Study of Topical AC-203 in Patients With Bullous Pemphigoid | | treatment | 2 | terminated |
| NCT04469582
| The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors | No drug interventions | Not Available | Not Available | unknown_status |
| NCT01265082
| Explore the Mechanisms of Pruritus in Bullous Pemphigoid Patients During Remission | No drug interventions | Not Available | Not Available | unknown_status |
| NCT04128176
| Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous Pemphigoid | | treatment | 3 | withdrawn |
| NCT05594472
| Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid | | treatment | 3 | recruiting |
| NCT01571895
| Pilot Efficacy and Safety Study of Oral DF2156A in Patients With Active Bullous Pemphigoid | No drug interventions | treatment | 2 | terminated |
| NCT01408550
| Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids | No drug interventions | treatment | 3 | completed |
| NCT04563923
| Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody | | treatment | 2 | completed |
| NCT03099538
| Ixekizumab in the Treatment of Bullous Pemphigoid | | treatment | 2 | completed |
| NCT04612790
| A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid. | | treatment | 3 | terminated |
| NCT02360202
| Evaluation of Fluid Retention Due to Superpotent Topical Corticosteroid | | prevention | 4 | unknown_status |
| NCT02874079
| Genetic Susceptibility and Influence of the Microbiomae in Bullous Pemphigoid | No drug interventions | basic_science | Not Available | unknown_status |
| NCT04206553
| A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid | | treatment | 2 / 3 | active_not_recruiting |
| NCT03926377
| Influence of Dermocorticoids on Bone Mineral Density in Patients With Bullous Pemphigoid | | treatment | 4 | recruiting |
| NCT05061771
| Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP) | | treatment | 3 | withdrawn |
| NCT06213909
| Retrospective Study of the Effects of Sub-pathologic Phenotypes of BP on Clinical Management and Prognosis | No drug interventions | Not Available | Not Available | recruiting |
| NCT05267600
| A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid (BALLAD) | | treatment | 2 / 3 | active_not_recruiting |
| NCT05906706
| Compassionate Use of Dupilumab for Adult Patients With Bullous Pemphigoid | | Not Available | Not Available | available |
| NCT06479018
| Deciphering IL-17-dependant Inflammatory Response in Bullous Pemphigoid | | basic_science | Not Available | recruiting |
| NCT03636763
| Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid? | No drug interventions | Not Available | Not Available | unknown_status |
| NCT00809822
| Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids. | No drug interventions | treatment | 2 | completed |
| NCT00472030
| Efficacy and Safety of Omalizumab in Bullous Pemphigoid | | treatment | 4 | completed |
| NCT02837965
| Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid | | Not Available | Not Available | completed |
| NCT01688882
| Safety, Efficacy and PK/PD of QGE031 vs. Placebo in Patients With Active Bullous Pemphigoid Despite Oral Steroid Treatment | | treatment | 2 | terminated |
| NCT05366127
| Validation of a Simplified Severity Score (Investigator Global Assessment: IGA) in Bullous Pemphigoid | No drug interventions | Not Available | Not Available | not_yet_recruiting |
| NCT02883894
| Interest of Dosage of Anti-PB230, Anti-PB180 and Cytokines for Monitoring of Patients Suffering From Bullous Pemphigoid | No drug interventions | Not Available | Not Available | completed |
| NCT05284929
| Human Leukocyte Antigen Class II (DRB1 and DQB1) Alleles and Haplotypes Frequencies in Patients With Pemphigus Vulgaris Among the Russian Population | No drug interventions | Not Available | Not Available | unknown_status |
| NCT05984381
| Efficacy and Safety of add-on Dapsone Versus add-on Methotrexate in Patients With Bullous Pemphigoid | | treatment | 4 | recruiting |
| NCT04035733
| rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects | No drug interventions | treatment | 2 | completed |
| NCT02502903
| Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders | No drug interventions | treatment | 1 | completed |
| NCT06371417
| Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) | No drug interventions | treatment | 1 | recruiting |